Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors

BACKGROUND: Cyclin dependent kinase inhibitors (CdK4/6i) changed the course of hormone receptor positive (HR+) HER2 negative (HER2-) metastatic breast cancer (mBC). To date, no factors have been shown to predict response to CdK4/6i. Neutrophil-to-lymphocyte ratio (NLR), an indicator of the host syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Rottier, Pauline, Emile, George, Johnson, Alison, Levy, Christelle, Allouache, Djelila, Hrab, Ioana, Segura, Carine, Morel, Adeline, Villemin, Maud, Dubot-Poitelon, Coraline, Boismoreau, Louis, Cherifi, François, Lequesne, Justine, Da Silva, Angélique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893782/
https://www.ncbi.nlm.nih.gov/pubmed/36741710
http://dx.doi.org/10.3389/fonc.2022.1105587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893782/
https://www.ncbi.nlm.nih.gov/pubmed/36741710
http://dx.doi.org/10.3389/fonc.2022.1105587

Ejemplares similares